Chemotherapy for anaplastic oligodendroglioma

Journal of Clinical Oncology

Volumn 12, Issue 10, 1994, Pages 2013-2021

  Cairncross, Gregory ^a   Macdonald, David ^b   Ludwin, Samuel ^b   Lee, Donald ^b   Cascino, Terrence ^b   Buckner, Jan ^b   Fulton, Dorcas ^b   Dropcho, Edward ^b   Stewart, David ^b   Schold Jr , Clifford ^b   Wainman, Nancy ^b   Eisenhauer, Elizabeth ^b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; CREATININE; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN DISEASE; BRAIN HEMORRHAGE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG RESPONSE; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE; OLIGODENDROGLIOMA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SUBDURAL HEMATOMA; TUMOR VOLUME;

EID: 0027972896     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.10.2013     Document Type: Article

References (47)

1. Walker MD, Alexander E, Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333-343, 1978
2. Macdonald DR, Cascino TL, Schold SC, et al: Response criteria for phase II studies of malignant glioma. J Clin Oncol 8:1277-1280, 1990
3. Cairncross JG, Macdonald DR, Pexman JHW, et al: Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology 38:724-726, 1988
4. Waiting CJ, Lee DH, Macdonald DR, et al: Steroid-induced MR changes in patients with recurrent malignant glioma. J Clin Oncol 12:1886-1889, 1994
5. Regan TJ, Bisel HF, Childs DS, et al: Controlled study of CCNU and radiation therapy in malignant astrocytoma. J Neurosurg 44:186-190, 1976
6. Garrett MJ, Hughes HJ, Freedman LS: A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma. Clin Oncol 4:71-76, 1978
7. Eagan RT, Childs DS, Layton DD, et al: Dianhydrogalactitol and radiation therapy: Treatment of supratentorial glioma. JAMA 24:2046-2050, 1979
8. Solero CL, Monfardini S, Brambilla C, et al: Controlled study with BCNU vs CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. Cancer Clin Trials 2:43-48, 1979
9. Cianfriglia F, Pompili A, Riccio A, et al: CCNU-chemotherapy of hemispheric glioblastoma multiforme. Cancer 45:1289-1299, 1980
10. Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980
11. EORTC. Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. J Neurosurg 55:27-31, 1981
12. Chin HW, Young AB, Maruyama Y: Survival and response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center. Cancer Treat Rep 65:45-51, 1981
13. Kristiansen K, Hagen S, Kollevold T, et al: Combined modality therapy of operated astrocytomas grade 3 and 4: Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time. Cancer 47:649-652, 1981
14. Chang CH, Horton J, Schoenfeld D, et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997-1007, 1983
15. Afra D, Kocsis B, Dobay J, et al: Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 59:106-110, 1983
16. Green SB, Byar DP, Walker MD, et al: Comparisons of carmustine, procarbazine, and high-dose methylprednisone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67:121-132, 1983
17. Ushio Y, Hayakawa T, Hasegawa H: Chemotherapy of malignant gliomas. Neurosurg Rev 7:3-12, 1984
18. Takakura K, Abe H, Tanaka R, et al: Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64:53-57, 1986
19. Trojanowski T, Peszynski J, Turowski K, et al: Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas. J Neurooncol 6:285-291, 1988
20. Fine HA, Dear KBG, Loeffler JS, et al: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597, 1993
21. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23:360-364, 1988
22. Macdonald DR, Gaspar LE, Cairncross JG: Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 27:573-574, 1990
23. Brown M, Cairncross JG, Vick NA, et al: Differential response of recurrent oligodendrogliomas versus astrocytomas to intravenous melphalan. Neurology 40:397-398, 1990 (abstr)
24. Saarinen UM, Pihko H, Makipernaa A: High-dose thiotepa with autologous bone marrow rescue in recurrent malignant oligodendroglioma: A case report. J Neurooncol 9:57-62, 1990
25. Glass J, Hochberg FH, Gruber ML, et al: The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytoma with PCV chemotherapy. J Neurosurg 76:741-745, 1992
26. Levin VA, Edwards MS, Wright DC, et al: Modified procarbazine, CCNU and vincristine (PCV-3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64:237-241, 1980
27. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
28. Levin VA, Crafts DS, Norman DM, et al: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47:329-335, 1977
29. Gaspar LE, Fisher BJ, Macdonald DR, et al: Malignant glioma: Timing of response to radiation therapy. Int J Radiat Oncol Biol Phys 25:877-879, 1993
30. Cairncross JG, Pexman JHW, Rathbone MP: Postsurgical contrast enhancement mimicking residual brain tumor. Can J Neurol Sci 12:75, 1985 (letter)
31. Cairncross JG, Pexman JHW, Rathbone MP, et al: Postoperative contrast enhancement in brain tumor patients. Ann Neurol 17:570-572, 1985
32. Cascino TL, Kimmel DW, Dinapoli RP, et al: Report of four cases with a resolving syndrome which otherwise simulates recurrent brain tumor. Neurology 38:306, 1988 (abstr)
33. Curran WJ Jr, Scott CB, Horton J, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993
34. Grant R, Liang B, Page MA, et al: Age influences chemotherapy response in glioma irrespective of tumor grade. Ann Neurol 32:289-290, 1992
35. DeVita VT Jr. Principles of chemotherapy, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincott, 1993, pp 276-292
36. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic glioma in adults - Prognostic importance of extent of resection and prior low grade glioma. J Neurosurg 71:487-493, 1989
37. Van Meyel DJ, Ramsay DA, Casson AG, et al: p53 mutation, expression and DNA ploidy in evolving astrocytic gliomas: Evidence for two pathways of progression. J Natl Cancer Inst 86:1011-1017, 1994
38. Smith MT, Ludwig CL, Godfrey AD, et al: Grading of oligodendrogliomas. Cancer 52:2107-2114, 1983
39. Kros JM, Troost D, van Eden CJ, et al: Oligodendroglioma:oligodendroglioma: A comparison of two grading systems. Cancer 61:2257-2259, 1988
40. Shaw EG, Scheithauer BW, O'Fallon JR, et al: Oligodendrogliomas: The Mayo Clinic experience. J Neurosurg 76:428-434, 1992
41. Kernohan JW, Sayre GP: Tumors of the central nervous system, in Atlas of Tumor Pathology, Section 10, Fascicle 34. Washington, DC, Armed Forces Institute of Pathology, 1952
42. Daumas-Duport C, Scheithauer BW, O'Fallon J, et al: Grading of astrocytomas, a simple and reproducible method. Cancer 62:2152-2165, 1988
43. Burger PC: Gliomas: Pathology, in Wilkins RH, Rengachary SS (eds): Neurosurgery (ed 1). New York, NY, McGraw-Hill, 1985, pp 553-563
44. Levin VA, Silver P, Hannigan J: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18:321-324, 1990
45. Coyle T, Bushunow P, Winfield J, et al: Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma. Cancer 69:2532-2540, 1992
46. Mason WP, DeAngelis LM: Procarbazine, CCNU, Vincristine (PCV) chemotherapy (CT) for benign oligodendrogliomas. Neurology 44:262-263, 1994. (suppl 2)
47. Kyritsis AP, Yung WKA, Bruner J, et al: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32:365-371, 1993